Abstract
The article covers issues of etiology and pathogenesis of papilloma viral infection as well as current concepts of the role of immune mechanisms in the development of an infectious process. It also presents the results of a comparative clinical study of the efficacy and safety of Ingaron (γ-interferon) in the complex therapy of anogenital papilloma viral infection.
Publisher
Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov
Reference19 articles.
1. Laurent R., Kienzler J.L. Epidemiology of HPV infections. Clin Dermatol 1985 Oct-Dec; 3(4): 64-70.
2. Bonnez W., Reichman R.C. Papillomaviruses. In: Mandell G.L., Bennett J.E., Dolin R., eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Philadelphia, Pa: Churchill Livingstone 1990; 1387-1400.
3. Beutner K.R., Tyring S. Human papillomavirus and human disease. Am J Med. 1997 May 5; 102(5A): 9-15.
4. Alani R.M., Munger K. Human papillomaviruses and associated malignancies. J Clin Oncol 1998 Jan; 16(1): 330-7.
5. Greenlee R.T., Hill-Harmon M.B., Murray T. Cancer statistics, 2001. CA Cancer J Clin 2001 Jan-Feb; 51(1): 15-36.